" class="no-js "lang="en-US"> Companies Archive - Page 21 of 145 - Medtech Alert
Wednesday, July 01, 2026

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
1448 Results.

View Company

 Nitra | Pharmtech Focus

Nitra

View Company

 Plume | Pharmtech Focus

Plume

View Company

 Université Paris Cité | Pharmtech Focus

Université Paris Cité

View Company

 Medison Pharma | Pharmtech Focus

Medison Pharma

View Company

 Source BioScience | Pharmtech Focus

Source BioScience

View Company

 hVIVO | Pharmtech Focus

hVIVO

View Company

 Open Orphan | Pharmtech Focus

Open Orphan

View Company

 Leucadia Therapeutics | Pharmtech Focus

Leucadia Therapeutics

View Company

 Brii Biosciences | Pharmtech Focus

Brii Biosciences

View Company

 Porton Advanced Solutions | Pharmtech Focus

Porton Advanced Solutions

Load More Results